+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

L

Actively Recruiting

This research collects long-term data on patients treated with the GORE4 TAG4 Conformable Thoracic Stent Graft with ACTIVE CONTROL System, focusing on thoracic endovascular aortic repair TEVAR for descending thoracic aorta lesions. The study aims to observe outcomes over ten years to confirm that TEVAR remains a suitable treatment option for the right patients in routine clinical practice. Participants have been or will be treated with the specified device as part of their standard care. This observational registry tracks their progress without altering treatment. Data collection includes patients with different lesion types such as aneurysms and dissections, with follow-up extending to ten years after the initial procedure. During the study, participants undergo regular monitoring through standard clinical visits. Researchers collect data on device performance, lesion status, complications, and patient outcomes like mortality, stroke, renal function, and device integrity. The study tracks both short-term events within 30 days post-procedure and long-term outcomes for up to ten years to evaluate the devices durability and safety.

Age: 18Years +All Genders
37 locations
M

Actively Recruiting

Researchers are conducting a long-term observational study to collect and compare clinical data on cochlear implant systems, specifically MED-EL CI systems, in both children and adults. This study aims to improve understanding of the clinical effectiveness of these implants over time, addressing challenges in comparing data across different clinics due to varied measures and procedures. The study is sponsored by MED-EL Elektromedizinische Gerte GmbH. The study involves collecting anonymized clinical data from participants who have received or will receive MED-EL cochlear implants as part of their usual clinical care. Data is systematically gathered through a secure, cloud-based platform at consistent time intervals, enabling longitudinal analysis of hearing outcomes over a period of up to five years. This includes measures such as hearing threshold levels, quality of hearing in adults, and auditory development in children. Participants will be monitored according to their regular clinical routines without any experimental treatment assigned by the study. Researchers will collect evaluations including hearing thresholds, auditory development scores, and quality of hearing assessments at multiple time points. The study will continue collecting data until 2030, supporting long-term follow-up of hearing outcomes and device performance in real-world settings.

All AgesAll Genders
3 locations
I

Actively Recruiting

Researchers are conducting an international multicenter prospective observational study focused on patients with symptomatic, radiologically confirmed single- or multilevel contiguous thoracolumbar T1 to L5 fractures caused by primary osteoporosis. The study includes both insufficiency fractures confirmed by MRI and low-energy traumatic fractures confirmed by CT or MRI. It aims to evaluate how well the Osteoporotic Fracture OF classification-based scoring system guides treatment decisions for these fractures, comparing outcomes when treatment aligns or does not align with the OF score recommendations. Participants will be classified using the OF system from OF 1 to OF 5 based on the severity of their fractures. Treatment decisions are categorized as either nonsurgical or surgical, with patients grouped according to whether their treatment matches the OF score guidance Accordance group or differs from it Discordance group. The initial treatment decision day is designated as Day 0, and patients will be followed clinically at discharge, 6 weeks, 3 months, 6 months, and 12 months. Surgical interventions may include various types of posterior stabilization procedures with or without augmentation or osteotomy. During the study, participants will undergo assessments to measure their return to mobility, which is the primary outcome within the first 3 months after treatment. Secondary outcomes include evaluations of clinical status, pain levels, daily activities, quality of life, and complications related to surgery or fracture subtype over a 12-month period. Researchers will collect data through clinical follow-ups at specified intervals, tracking treatment type, functional recovery, and patient satisfaction. The total follow-up duration extends up to one year to monitor long-term results and health economic impacts.

Age: 50Years +All Genders
15 locations